14297-28-0

Basic information

• Product Name: [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate
• Synonyms: [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate
• CAS NO: 14297-28-0
• Molecular Formula: C₁₈H₁₄ClF₂N₇O₄
• Molecular Weight: 174.2
• Mol File: 14297-28-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate(14297-28-0)
• EPA Substance Registry System: [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate(14297-28-0)

Safety Data

• Hazardous Substances Data: 14297-28-0(Hazardous Substances Data)

Usage

General Description

The chemical "[4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate" is a complex organic compound with a molecular structure consisting of various functional groups. It contains a phenyl ring with a methoxy group and a 2-chloro-4,5-difluoro-benzoate moiety, as well as a hydrazinylidene-methyl group attached to a 5-aminotetrazol-1-yl and an acetyl group. [4-[[[2-(5-aminotetrazol-1-yl)acetyl]hydrazinylidene]methyl]-2-methoxy-phenyl] 2-chloro-4,5-difluoro-benzoate may have potential applications in pharmaceuticals, agrochemicals, or material science, and its properties and reactivity should be further investigated to fully understand its potential uses and effects.

Upstream product

• 6940-46-1 N-(α-bromo-isovaleryl)-glycine 
• 74088-26-9 N-(N-benzyloxycarbonyl-DL-valyl)-glycine 
• 40331-73-5 4-isopropyl-3-(2-nitro-phenylsulfanyl)-oxazolidine-2,5-dione 
• 56-40-6 glycine 
• 2816-12-8 4-isopropyl-2,5-oxazolidinedione 
• 516-06-3 D,L-valine 
• 7801-65-2 N-(N-benzyloxycarbonyl-DL-valyl)-glycine ethyl ester 
• 1149-26-4 N-benzyloxycarbonylvaline 
• 7664-41-7 ammonia 
• 85864-65-9 [(S)-2-(2-{(S)-2-[2-((S)-2-Amino-3-phenyl-propionylamino)-acetylamino]-4-methyl-pentanoylamino}-acetylamino)-3-methyl-butyrylamino]-acetic acid 
• 27109-47-3 2-bromoisovaleryl chloride 
• 10323-40-7 2-bromoisovaleric acid 

Downstream Products

• 16944-60-8 3-isopropyl-piperazine-2,5-dione 
• 78-82-0 Isobutyronitrile 
• 56-40-6 glycine 
• 640-68-6 D-Val-OH 
• 69288-25-1 alanyl=>valyl=>glycine 
• 95753-63-2 DL-5-isopropyl-3-<4-<(2S)-Fmocamino-2-methoxycarbonylethyl>phenyl>-2-thiohydantoin 

Relevant articles and documents

METHOD FOR PRODUCING GAMMA -GLUTAMYL-VALYL-GLYCINE CRYSTAL

The present invention provides a method for efficiently producing a γ-glutamyl-valyl-glycine crystal. Specifically, the present invention provides a method for producing a γ-glutamyl-valyl-glycine crystal, which includes the steps of: preparing a mixed solution of valyl-glycine or a salt thereof and γ-glutamyl-valyl-glycine, wherein the mixed solution contains valyl-glycine or the salt thereof in an amount of 20 mass % or more relative to the mass of γ-glutamyl-valyl-glycine; adjusting the amount of valyl-glycine or the salt thereof in the prepared mixed solution to 0.1 mass % or more and less than 20 mass % relative to the mass of γ-glutamyl-valyl-glycine to prepare a γ-glutamyl-valyl-glycine solution; and subjecting the γ-glutamyl-valyl-glycine solution to a crystallization procedure to produce the γ-glutamyl-valyl-glycine crystal.

19 F nuclear magnetic resonance for the control of peptide synthesis.

-